WORLD OF MICROBIOLOGY AND IMMUNOLOGY Anaphylaxis
17
•
era Peptostreptococcus, Streptococcus, and Staphylococcus.
Rod-shaped bacteria that stain Gram-negative include
Bacteroides, Campylobacter, and Fusobacterium. Finally,
Gram-negative spherical bacteria are represented by the genus
Veillonella.
The word anaerobic means “life without air.” In the
human body, regions that can be devoid of oxygen include the
interior of dental plaquethat grows on the surface of teeth and
gums, the gastrointestinal tract, and even on the surface of the
skin. Normally the anaerobic bacteria growing in these envi-
ronments are benign and can even contribute to the body’s
operation. Most of the bacteria in the body are anaerobes.
However, if access to underlying tissues is provided due to
injury or surgery, the bacteria can invade the new territory and
establish an infection. Such bacteria are described as being
opportunistic pathogens. That is, given the opportunity and the
appropriate conditions, they are capable of causing an infec-
tion. Typically, anaerobic bacteria cause from five to ten per
cent of all clinical infections.
Anaerobic infections tend to have several features in
common. The infection is usually accompanied by a foul-
smelling gas or pus. The infections tend to be located close to
membranes, particularly mucosal membranes, as the infection
typically begins by the invasion of a region that is bounded by
a membrane. Anaerobic infections tend to involve the destruc-
tion of tissue, either because of bacterial digestion or because
of destructive enzymesthat are elaborated by the bacteria.
This type of tissue damage is known as tissue necrosis. The
tissue damage also frequently includes the production of gas
or a fluid.
There are several sites in the body that are prone to
infection by anaerobic bacteria. Infections in the abdomen can
produce the inflammationof the appendix that is known as
appendicitis. Lung infections can result in pneumonia, infec-
tion of the lining of the lung (empyema) or constriction of the
small air tubes known as bronchi (bronchiectasis). In females,
pelvic infections can inflame the lining of the uterus
(endometritis). Mouth infections can involve the root canals or
gums (gingivitis). Infections of the central nervous system can
lead to brain and spinal cord infections. Infection of the skin,
via bites and other routes of entry, causes open sores on the
skin and tissue destruction. An example is that massive and
potentially lethal tissue degradation, which is known as necro-
tizing fascitis, and which is caused by group A b-hemolytic
Streptococcus. Finally, infection of the bloodstream (bac-
teremia) can prelude the infection of the heart (endocarditis).
The diagnosis of anaerobic infections is usually based
on the symptoms, site of the infection and, if the infection is
visible, on both the appearance and smell of the infected area.
Most of the bacteria responsible for infection are susceptible
to one or more antibiotics. Treatment can be prolonged, how-
ever, since the bacteria are often growing slowly and since
antibiotics rely on bacterial growthto exert their lethal effect.
In the case of infections that create tissue destruction, the
removal of the affected tissue is an option to prevent the
spread of the infection. Amputation of limbs is a frequent
means of dealing with necrotizing fascitis, an infection that is
inside of tissue (and so protected from antibiotics and the
host’s immune response) and is exceptional in that it can
swiftly spread.
See alsoBacteria and bacterial infections
ANAPHYLACTIC SHOCK•seeIMMUNITY: ACTIVE,
PASSIVE, AND DELAYED
AAnaphylaxisNAPHYLAXIS
Anaphylaxis is a severe allergic reaction. The symptoms
appear rapidly and can be life threatening.
The symptoms of anaphylaxis include the increased out-
put of fluid from mucous membranes (e.g., passages lining the
nose, mouth, and throat), skin rash (e.g., hives), itching of the
eyes, gastrointestinal cramping, and stiffening of the muscles lin-
ing the throat and trachea. As a result of the latter, breathing can
become difficult. These symptoms do not appear in every case.
However, some sort of skin reaction is nearly always evident.
Anaphylaxis results from the exposure to an antigen
with which the individual has had previous contact, and has
developed a heightened sensitivity to the antigen. Such an
antigen is also known as an allergen. The allergen binds to the
specific immune cell (e.g., immunoglobulin E, also known as
IgE) that was formed in response to the initial antigen expo-
sure. IgE is also associated with other specific cells of the
immune systemthat are called basophils and mast cells. The
basophils and mast cells react to the binding of the allergen-
IgE complex by releasing compounds that are known as medi-
ators (e.g, histamine, prostaglandin D2, trypase). Release of
mediators does not occur when IgE alone binds to the
basophils or mast cells.
The release of the mediators triggers the physiological
reactions. For example, blood vessels dilate (become larger in
diameter) and fluid can pass across the blood vessel wall more
easily. Because the immune system is sensitized to the partic-
ular allergen, and because of the potent effect of mediators, the
development of symptoms can be sudden and severe. A condi-
tion called anaphylactic shock can ensue, in which the body’s
physiology is so altered that failure of functions such as the
circulatory system and breathing can occur. For example, in
those who are susceptible, a bee sting, administration of a
penicillin-type of antibiotic, or the ingestion of peanuts can
trigger symptoms that can be fatal if not addressed immedi-
ately. Those who are allergic to bee stings often carry medica-
tion with them on hikes.
Anaphylaxis occurs with equal frequency in males and
females. No racial predisposition towards anaphylaxis is
known. The exact number of cases is unknown, because many
cases of anaphylaxis are mistaken for other conditions (e.g.,
food poisoning). However, at least 100 people die annually in
the United States from anaphylactic shock.
See alsoAllergies; Immunoglobulins and immunoglobulin
deficiency syndromes
womi_A 5/6/03 1:06 PM Page 17